share_log

維亞生物：完成完全贖回2.8億美元1.00%於二零二五年到期的有擔保可轉換債券（債券代號：40514）

VIVA BIOTECH: COMPLETION OF FULL REDEMPTION OF US$280 MILLION 1.00 PER CENT GUARANTEED CONVERTIBLE BONDS DUE 2025 (STOCK CODE: 40514)

香港交易所 ·  Jan 3 04:47
Summary by Moomoo AI
維亞生物科技控股集團（「本公司」）已完成對其全資附屬公司Viva Biotech Investment Management Limited發行的2.8億美元1.00%有擔保可轉換債券的全部贖回，該債券原定於2025年到期。根據債券條款，持有本金總額約1.366億美元的債券持有人已於2023年12月30日行使贖回權，贖回金額為本金的103.08%加上應計未付利息。本公司已申請撤回該可轉換債券在香港聯合交易所有限公司的上市，預計撤回將於2024年1月10日生效。公司董事會認為，此次贖回不會對公司財務狀況造成重大影響。董事會成員包括三名執行董事、一名非執行董事及三名獨立非執行董事。
維亞生物科技控股集團（「本公司」）已完成對其全資附屬公司Viva Biotech Investment Management Limited發行的2.8億美元1.00%有擔保可轉換債券的全部贖回，該債券原定於2025年到期。根據債券條款，持有本金總額約1.366億美元的債券持有人已於2023年12月30日行使贖回權，贖回金額為本金的103.08%加上應計未付利息。本公司已申請撤回該可轉換債券在香港聯合交易所有限公司的上市，預計撤回將於2024年1月10日生效。公司董事會認為，此次贖回不會對公司財務狀況造成重大影響。董事會成員包括三名執行董事、一名非執行董事及三名獨立非執行董事。
VIA Biotechnology Holdings Group (the “Company”) has completed the redemption of the entire $2.8 million $1.00% guaranteed convertible bond issued to its wholly-owned subsidiary Viva Biotech Investment Management Limited, which is originally scheduled to mature in 2025. Under the terms of the Notes, bondholders with a total principal amount of approximately US$1.366 billion exercised their redemption right on December 30, 2023 with a redemption amount of 103.08% of the principal plus accrued interest accrued. The Company has requested withdrawal from the listing of the Convertible Bond on the Hong Kong Stock Exchange Limited, which is expected to take effect on 10 January 2024. The Board of Directors considers that this redemption will not have a material impact on the Company's financial condition. Board members include three executive directors, one non-executive director and three independent non-executive directors.
VIA Biotechnology Holdings Group (the “Company”) has completed the redemption of the entire $2.8 million $1.00% guaranteed convertible bond issued to its wholly-owned subsidiary Viva Biotech Investment Management Limited, which is originally scheduled to mature in 2025. Under the terms of the Notes, bondholders with a total principal amount of approximately US$1.366 billion exercised their redemption right on December 30, 2023 with a redemption amount of 103.08% of the principal plus accrued interest accrued. The Company has requested withdrawal from the listing of the Convertible Bond on the Hong Kong Stock Exchange Limited, which is expected to take effect on 10 January 2024. The Board of Directors considers that this redemption will not have a material impact on the Company's financial condition. Board members include three executive directors, one non-executive director and three independent non-executive directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more